DOI QR코드

DOI QR Code

Eugenol과 1α,25-dihydroxyvitamin D3의 병합처리에 의한 HL-60 세포의 분화 유도

Cooperative Induction of HL-60 Cell Differentiation by Combined Treatment with Eugenol and 1α,25-Dihydroxyvitamin D3

  • 오미경 (가톨릭대학교 의과대학 자연과학교실) ;
  • 박선주 (가톨릭대학교 의과대학 자연과학교실) ;
  • 김남훈 (가톨릭대학교 의과대학 자연과학교실) ;
  • 조진경 (가톨릭대학교 의과대학 자연과학교실) ;
  • 진종률 (가톨릭대학교 의과대학 내과) ;
  • 김인숙 (가톨릭대학교 의과대학 자연과학교실)
  • Oh, Mi-Kyung (Department of Natural Sciences, College of Medicine, The Catholic University of Korea) ;
  • Park, Seon-Joo (Department of Natural Sciences, College of Medicine, The Catholic University of Korea) ;
  • Kim, Nam-Hoon (Department of Natural Sciences, College of Medicine, The Catholic University of Korea) ;
  • Cho, Jin-Kyung (Department of Natural Sciences, College of Medicine, The Catholic University of Korea) ;
  • Jin, Jong-Youl (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kim, In-Sook (Department of Natural Sciences, College of Medicine, The Catholic University of Korea)
  • 발행 : 2007.09.30

초록

Eugenol은 여러가지 향신료에 있는 필수 오일의 주요 성분으로서 악성 종양 세포의 성장을 저해하고 사멸을 유도한다고 보고되었다. 본 연구에서는 eugenol이 세포 분화 유도에 관여하는지를 조사하기 위하여 HL-60 전골 수성 백혈병 세포의 분화에 미치는 eugenol의 효과를 연구하였다. HL-60 세포에 eugenol (150 ${\mu}M$)을 가했을 때 세포성장이 저해되었으며 $1,25(OH)_{2}$ vit $D_{3}$ (3 nM)와 병합처리시에는 더 큰 저해효과를 보였다. 이 때, eugenol은 $1,25(OH)_{2}$ vit $D_{3}$에 의해 유도되는 세포주기의 $G_{0}/G_{1}$단계 정지를 더욱 증가시킴을 알 수 있었다. 또한, eugenol과 $1,25(OH)_{2}$ vit $D_{3}$를 병합처리 하였을 때에는 $G_{0}/G_{1}$단계의 정지와 관련된 세포주기 조절인자인 p27 level를 상호 협동적으로 증가시켰을 뿐만 아니라 cyclin A, cdk2, cdk4 level를 감소시켰다. 또한 유세포분석실험을 통하여, CD14 (단핵세포 표지 인자)의 발현이 eugenol과 $1,25(OH)_{2}$ vit $D_{3}$를 병합처리한 세포에서 단독처리시보다 더 증가함을 알 수 있었다. 이러한 결과들은 eugenol이 $1,25(OH)_{2}$ vit $D_{3}$와 상호협동적으로 작용하여 저농도의 $1,25(OH)_{2}$ vit $D_{3}$에 의해 자극된 세포 분화 신호를 더욱 더 증대 시킴을 나타낸다. 이러한 eugenol에 의한 세포 분화 유도 작용은 암의 화학적예방 효과에 유용하게 응용될 수 있을 것으로 기대된다.

Eugenol (4-allyl-2-methoxyphenol) is a main component of essential oils obtained from various spices. Recent reports have shown that eugenol induces growth inhibition and apoptosis of malignant tumor cells. In this study, the stimulatory effect of eugenol on cell differentiation was investigated in HL-60 promyelocytic leukemia cells. When HL-60 cells were treated in combination with 150 ${\mu}M$ of eugenol and 3 nM of $1{\alpha},25-dihydroxyvitamin$ $D_{3}$, cell growth was slower than that of cells treated with eugenol or $1{\alpha},25-dihydroxyvitamin$ $D_{3}$ alone. Eugenol enhanced low dose of $1{\alpha,25-dihydroxyvitamin }$ $D_{3}-induced$ a $G_{0}/G_{1}$ phase arrest in cell cycle. Consistent with this, combined treatment of eugenol and $1{\alpha},25-dihydroxyvitamin$ $D_{3}$ cooperatively increased p27 level and decreased cyclin A, cdk 2 and cdk 4 levels, which are cell cycle regulators related to $G_{0}/G_{1}$ arrest. According to flow cytometric analysis, the expression of CD14 (monocytic differentiation marker) was more increased in the cells co-treated with eugenol and $1{\alpha},25-dihydroxyvitamin$ $D_{3}$. These results indicate that eugenol potentiates cell differentiation mediated by $1{\alpha},25-dihydroxyvitamin$ $D_{3}$ of suboptimal concentration. The differentiation-inducing property of eugenol maybe contributes to chemopreventive activity of cancer.

키워드

참고문헌

  1. Abe, E., C. Miyaura. H. Sakagami, M. Takeda, K. Konno, T. Yamazaki, S. Yoshiki and T. Suda. 1981. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. USA 78, 4990-4994 https://doi.org/10.1073/pnas.78.8.4990
  2. Douer, D. 2002. Advances in the treatment of relapsed acute promyelocytic leukemia. Acta Haematol. 107, 1-17 https://doi.org/10.1159/000046623
  3. Evans, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Science 13, 889-895
  4. Ghosh, R., N. Nadiminty, J. E. Fitzpatrick, W. L. Alworth, T. J. Slaga and A. P. Kumar. 2005. Eugenol Causes Melanoma Growth Suppression through Inhibition of E2F1 Transcriptional Activity. J. Biol. Chem. 280, 5812-5819 https://doi.org/10.1074/jbc.M411429200
  5. Huang, M. E., Y. C. Ye, S. R. Chen, J. R. Chai, J. X. Lu, L. Zhoa, L. J. Gu and Z. Y. Wang. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567-572
  6. Inoue, T., J. Kamiyama and T. Sakai. 1999. Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements. J. Biol. Chem. 274, 32309-32317 https://doi.org/10.1074/jbc.274.45.32309
  7. Jung, S. J., Y. Y. Lee, S. Pakkala, S. de Vos, E. Elstner, A. W. Norman, J. Green, M. Uskokovic and H. P. Koeffler. 1994. $1,25(OH)_{2}$-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia. Leuk. Res. 18, 453-463 https://doi.org/10.1016/0145-2126(94)90081-7
  8. Mangelsdorf, D. J., H. P. Koeffler, C. A. Donaldson, J. W. Pike and M. R Haussler. 1984. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J. Cell Biol. 98, 391-398 https://doi.org/10.1083/jcb.98.2.391
  9. Mistry, A. R., E. W. Pedersen, E. Solomon and D. Grimwade. 2003. The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Rev. 17, 71-97 https://doi.org/10.1016/S0268-960X(02)00075-9
  10. Miyauchi, J. 1999. All-trans retinoic acid and hematopoietic growth factors regulating the growth and differentiation of blast progenitors in acute promyelocytic leukemia. Leuk. Lymphoma 33, 267-280 https://doi.org/10.3109/10428199909058426
  11. Mu, Z. M., K. V. Chin, J. H. Liu, G. Lozano and K. S. Chang. 1994. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14, 6858-6867 https://doi.org/10.1128/MCB.14.10.6858
  12. Tallman, M. S., J. W. Andersen, C. A Schiffer, F. R Appelbaum, J. H. Feusner, A. Ogden, L. Shepherd, C. Willman, C. D. Bloomfield, J. M. Rowe and P. H. Wiernik. 1997. All-trans-retinoic acid in acute promyelocytic leukemia. N. Engl. J. Med. 337, 1021-1028 https://doi.org/10.1056/NEJM199710093371501
  13. Umesono, K., K. K. Murakami, C. C. Thompson and R M. Evans. 1991. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65, 1255-1266 https://doi.org/10.1016/0092-8674(91)90020-Y
  14. Verstuyf, A., C. Mathieu, L. Verlinden, M. Waer, B. K. Tan and R Bouillon. 1995. Differentiation induction of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis). J. Steroid Biochem. Mol. Biol. 53, 431-441 https://doi.org/10.1016/0960-0760(95)00089-I
  15. Wang, Q., J. S. Harrison, M. Uskokovic, A Kutner and G. P. Studzinski. 2005. Translational study of vitamin D differentiation therapy of myeloid leukemia:effects of the combination with a p38 MAPK inhibitor and an antioxidant. Leukemia 19, 1812-1817 https://doi.org/10.1038/sj.leu.2403916
  16. Wang, Q., H. Salman, M. Danilenko and G. P. Studzinski. 2005. Cooperation between antioxidants and 1,25-Dihydroxyvitamin D3 in induced of leukemia HL60 cell differentiation through the JNK/ AP-1/Egr-1 pathway. J. Cell. Physiol. 204, 964-974 https://doi.org/10.1002/jcp.20355
  17. Yoo, C. B., K. T. Han, K. S. Cho, J. Ha, H. J. Park, J. H. Nam, U. H. Kil and K. T. Lee. 2005. Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer Lett. 224, 41-52
  18. Zhou, G. B., S. J. Chen and Z. Chen. 2005. Acute promyelocytic leukemia: a model of molecular target based therapy. Hematology 10, 270-280 https://doi.org/10.1080/10245330512331390519